PUBLISHER: The Business Research Company | PRODUCT CODE: 2098714
PUBLISHER: The Business Research Company | PRODUCT CODE: 2098714
Genetic counseling services are professional healthcare services that provide individuals and families with specialized advice regarding hereditary diseases, genetic disorders, and potential health-related risks. These services help interpret genetic testing outcomes, assess the likelihood of disease occurrence or recurrence, and support informed decision-making related to family planning, preventive care, and treatment options.
The primary service categories of genetic counseling services include prenatal, pediatric, adult, cancer, and other service types. Prenatal services involve specialized guidance aimed at evaluating genetic risks and inherited disorders before or throughout pregnancy. These services are offered through delivery modes such as in-person consultations and telehealth or online platforms. Key applications include risk evaluation, disease management, preventive healthcare, and others, and they are utilized by end users such as hospitals, clinics, diagnostic centers, research institutions, and others.
Tariffs are influencing the genetic counseling services market by increasing the cost of genetic testing kits, sequencing technologies, and imported diagnostic infrastructure that support counseling workflows, creating financial pressure on healthcare providers. This is especially evident in regions dependent on imported genomic technologies such as Asia-Pacific and parts of Europe. Hospitals, diagnostic laboratories, and research institutes are the most affected end users due to reliance on high-throughput sequencing systems and cloud-based genomic analysis tools. However, tariffs are also encouraging the development of localized genomic testing capabilities, expansion of domestic biotech manufacturing, and increased investment in regional precision medicine ecosystems, gradually improving accessibility and system resilience.
The genetic counseling services market size has grown rapidly in recent years. It will grow from $2.59 billion in 2025 to $2.91 billion in 2026 at a compound annual growth rate (CAGR) of 12.3%. The historical-period growth can be attributed to increasing prevalence of inherited genetic disorders, rising awareness of genetic testing in healthcare, expansion of hospital-based genetic counseling services, declining cost of genome sequencing technologies, and growth in oncology-related genetic testing applications.
The genetic counseling services market size is expected to see rapid growth in the next few years. It will grow to $4.67 billion in 2030 at a compound annual growth rate (CAGR) of 12.6%. The growth in the forecast period can be attributed to expansion of precision medicine adoption in healthcare systems, integration of AI-powered genomic interpretation tools, increasing telehealth penetration in genetic services, rising demand for preventive and predictive healthcare models, and growth in population-wide genetic screening programs. Key trends in the forecast period include expansion of tele-genetic counseling and remote care services, integration of pharmacogenomic counseling into routine healthcare practices, rising demand for prenatal and carrier screening counseling, growth of direct-to-consumer genetic counseling services, and expansion of cancer risk stratification and multi-gene panel counseling programs.
The growth in personalized medicine is expected to propel the growth of the genetic counseling services market going forward. Personalized medicine refers to a medical approach that tailors disease prevention, diagnosis, and treatment strategies to an individual's genetic profile, lifestyle, and environmental factors to improve healthcare outcomes. The growth in personalized medicine is increasing due to the rising use of genetic and molecular profiling, enabling more targeted treatments that improve effectiveness, reduce side effects, and support precise healthcare decision-making. Genetic counseling services support the growth of personalized medicine by helping individuals understand genetic testing results, assess inherited health risks, and make informed decisions regarding personalized treatment and preventive care strategies. For instance, in February 2024, according to the Personalized Medicine Coalition, a US-based professional membership organization, the FDA approved 16 new personalized treatments for patients with rare diseases in 2023, compared to six approvals in 2022. Therefore, the growth in personalized medicine is driving the growth of the genetic counseling services market.
Leading companies operating in the genetic counseling services market are focusing on expanding phenotype-based clinical assessment units to improve early diagnosis, risk assessment, and preventive healthcare for inherited disorders. A phenotype-based clinical assessment unit is a specialized healthcare facility that evaluates observable patient characteristics and clinical symptoms to identify disease patterns and support accurate diagnosis and personalized treatment planning. For example, in April 2026, RM Medical College Hospital and Research Centre, an India-based teaching hospital and research institution, launched a specialized genetic clinic in Tamil Nadu offering services such as genetic risk assessment, prenatal and preconception counseling, carrier screening, chromosomal analysis, molecular diagnostics, and guidance for rare and inherited disorders. The clinic also supports personalized treatment planning and clinical decision-making through expert consultations, advanced genetic testing interpretation, and family-based disease management services.
In February 2025, Tempus AI, Inc., a US-based healthcare technology company, acquired Ambry Genetics Corporation for an undisclosed consideration. Through this acquisition, Tempus sought to strengthen its precision medicine platform by expanding its genetic testing capabilities, particularly in hereditary disease and oncology-focused diagnostics, while also broadening its data-driven clinical and research offerings. Ambry Genetics Corporation is a US-based clinical genetic testing company offering genetic counseling services to help patients and healthcare providers interpret genetic test results and assess hereditary risk factors.
Major companies operating in the genetic counseling services market are Laboratory Corporation of America Holdings, Quest Diagnostics Incorporated, Eurofins Scientific SE, Exact Sciences Corporation, Revvity Inc., Natera Inc., Myriad Genetics Inc., NeoGenomics Inc., Guardant Health Inc.,GeneDx, Ambry Genetics Corporation, Fulgent Genetics Inc., Color Health Inc., 23andMe Holding Co., InformedDNA, Helix OpCo LLC, Genome Medical Inc., Lilac Insights Private Limited, Metis Genetics LLC, Clover Genetics Inc., Grey Genetics LLC, Sahaj Genetics Private Limited
North America was the dominant region in the genetic counseling services market in 2025. Asia-Pacific is expected to be the rapidly expanding region in the forecast period. The regions covered in genetic counseling services report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the genetic counseling services market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The genetic counseling services market consists of revenues earned by entities by providing services such as newborn screening counseling, reproductive genetic counseling, neurological genetic counseling, carrier screening counseling, and pharmacogenomic counseling. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
The genetic counseling services market research report is one of a series of new reports from The Business Research Company that provides genetic counseling services market statistics, including genetic counseling services industry global market size, regional shares, competitors with a genetic counseling services market share, detailed genetic counseling services market segments, market trends and opportunities, and any further data you may need to thrive in the genetic counseling services industry. This genetic counseling services market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Genetic Counseling Services Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses genetic counseling services market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for genetic counseling services ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The genetic counseling services market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.